CRISPR QC™ is proud to announce that co-founder Kiana Aran has been recognized by Inc. magazine as a top 200 Female Founder. This prestigious list highlights women entrepreneurs who are making a significant impact in their respective industries and driving change.
“As a female founder, I hope to inspire other women to have the courage and intellectual bravery to pursue their entrepreneurial goals”
“As a female founder, I hope to inspire other women to have the courage and intellectual bravery to pursue their entrepreneurial goals,” says Dr. Aran. “The development of CRISPR-Chip™ technology has proven to be incredibly valuable for the CRISPR industry, and I am thrilled to see the impact of my work. This recognition from Inc. magazine is incredibly rewarding and motivates me to continue pushing boundaries in biotechnology innovations. I am excited to further bridge the gap between the benches in my academic lab and effective commercial applications.”
CRISPR QC™ congratulates Kiana Aran on this well-deserved recognition and looks forward to her continued leadership.
About CRISPR QC™:
CRISPR QC™ provides innovative solutions for CRISPR research and development. The CRISPR-Chip™ is the core component of the CRISPR Analytics Platform™, which uniquely enables real-time, direct measurement of CRISPR activity. Our CRISPR Analytics Platform™ uses machine learning and data visualization to gain insights into gene editing and accelerate research. We strive to empower our customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by CRISPR editing.
About Inc:
The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning, multiplatform content reaches more than 50 million people each month across a variety of channels, including websites, newsletters, social media, podcasts, and print. For more information, visit www.inc.com.
